Implications of the MEDIOLA Trial Results in Relapsed Ovarian Cancer
Susana Banerjee, MBBS, PhD, discusses the significance of the long-term results of the MEDIOLA trial of patients with ovarian cancer.
MEDIOLA Update Shows Continued Efficacy for Triplet Therapy in Ovarian Cancer
Susana Banerjee, MBBS, PhD, discusses the updated results of the MEDIOLA trial of patients with ovarian cancer presented at the 2022 European Society for Medical Oncology Congress.
